Samlyn Capital’s Johnson & Johnson JNJ Stock Holding History

Samlyn Capital’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-404,866	Closed	-$63.1M	–	103
2023 Q3	$63.1M	Buy	+404,866	New	+$66.8M	1.03%	30

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Samlyn Capital's JNJ Position: Q4 2023 in Review

Samlyn Capital sold out of Johnson & Johnson (JNJ) in Q4 2023, closing a stake of 404,866 shares — an estimated $63.1M sold.

Samlyn Capital first reported a position in JNJ in Q3 2023 and held it in 1 quarter. The position peaked at $63.1M in Q3 2023. 3,868 funds tracked by Wall St. Rank hold JNJ as of Q4 2023.

Samlyn Capital reported no remaining Johnson & Johnson position as of Q4 2023 after selling out during the quarter.
Samlyn Capital sold 404,866 Johnson & Johnson shares in Q4 2023, an estimated $63.1M.
Samlyn Capital first reported a position in Johnson & Johnson in Q3 2023 and held it in 1 quarter.
Samlyn Capital's Johnson & Johnson position peaked at $63.1M in Q3 2023.
3,868 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2023.

Based on Samlyn Capital's 13F filing for Q4 2023, filed 14 Feb 2024.